Genmab A (GMAB) Return on Sales [ROS] (2023 - 2026)
Genmab A's Return on Sales [ROS] came in at 32.47% for the quarter ended Jun 30, 2026, up 12.38 percentage points from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Return on Sales [ROS] (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Genmab A reported Return on Sales [ROS] of 33.21%; for the year ended Dec 31, 2025, it was 28.63%, up 8.65 percentage points from the prior year.
- Return on Sales [ROS] carries a five-year change of -53.87 percentage points (years ended Dec 2020 to Dec 2025).
- Going back by year, Return on Sales [ROS] was 19.98% in the year ended Dec 31, 2024 (-1.03 pp), 21.01% in the year ended Dec 31, 2023 (-7.78 pp), 28.79% in the year ended Dec 31, 2022 (-6.79 pp) and 35.58% in the year ended Dec 31, 2021 (-46.92 pp).
- The five-year range for quarterly Return on Sales [ROS] is 11.11% (the quarter ended Jun 30, 2024) to 39.91% (the quarter ended Dec 31, 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 28.37% |
| 10 | Genmab A | 2.58 Bn | -2.80 Bn | 1.07 Bn | 32.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.47% |
| Mar 31, 2026 | 20.09% |
| Sep 30, 2025 | 44.91% |
| Jun 30, 2025 | 38.92% |
| Mar 31, 2025 | 26.29% |
| Sep 30, 2024 | 37.99% |
| Jun 30, 2024 | 30.30% |
| Mar 31, 2024 | 19.24% |
| Sep 30, 2023 | 35.76% |
API Access
Genmab A Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();